BGICC-Breast Gynecological & Immunooncology International Cancer Conference

https://www.facebook.com/share/p/1AMrBnRbvM/

Celebrating the Successful Completion of the 18th BGICC-Breast Gynecological & Immunooncology International Cancer Conference - Hesham ElGhazaly

https://oncodaily.com/voices/hesham-elghazaly-448830

https://www.facebook.com/share/p/1DeuWFqiW4/

Dr. Wafik S. El-Deiry, Chair of the Win Consortium in Precision Oncology, Director of the Cancer Center at Brown University, and Associate Dean at the The Warren Alpert Medical School of Brown University, joins BGICC-Breast Gynecological & Immunooncology International Cancer Conference 2026 to discuss the future of precision oncology and its role in improving global cancer care.

He highlights the importance of collaboration, equity, and access to molecular testing and targeted therapies, particularly in the MENA region and Africa. He explains how the Win Consortium uses molecular tumor boards, clinical trials, and innovative targeted therapy combinations to tailor treatment to individual patients’ tumors.

He also shares the promise of digital pathology and AI in expanding access to detailed molecular profiling and actionable targets worldwide. Dr. Wafik S. El-Deiry reflects on his research contributions, including the FDA approval of Dordaviprone for recurrent diffuse gliomas with H3 K27M mutations, emphasizing the potential of novel therapies and combinations to advance cancer care globally.

https://youtu.be/NuEZ2bNZRRQ?si=3lMo9h_hl8rWg6vf

CancerWorld

https://www.facebook.com/share/17q5CpTdGZ/

Dr. Rolf Stahel, Medical Oncologist from Switzerland and President of the ETOP IBCSG Partners Foundation, joins OncoDaily at BGICC-Breast Gynecological & Immunooncology International Cancer Conference 2026 to discuss the evolving landscape of lung cancer research and treatment. Dr. Stahel highlights the growing importance of molecular profiling in early-stage non-small cell lung cancer.

He explains why EGFR, ALK, and PD-L1 testing is essential to guide immunotherapy decisions in lung cancer and highlights the role of collaborative meetings and international cooperation in identifying key clinical questions, aligning global understanding, and improving patient-centered care. Tune in to learn how research-driven collaboration is shaping the future of thoracic oncology.

https://youtu.be/brTDlhMWT6g?si=RppsJbyjooBSH_jf

CancerWorld

𝐌𝐀𝐒𝐑𝐈 𝐆𝐄𝐍𝐎𝐌𝐈𝐂𝐒 & 𝐏𝐑𝐄𝐂𝐈𝐒𝐈𝐎𝐍 𝐌𝐄𝐃𝐈𝐂𝐈𝐍𝐄 𝐂𝐎𝐔𝐑𝐒𝐄 – 𝟏𝟖𝐭𝐡 𝐁𝐆𝐈𝐂𝐂

A powerful start to a transformative scientific journey.
Inspiring minds, groundbreaking insights, and cutting-edge knowledge exchange from day one.

🧬 Genomics shaping the future of medicine
🧠 Precision-driven clinical decision making
🌍 Global expertise, local impact
🤝 Collaboration advancing personalized healthcare

𝐌𝐨𝐔 𝐒𝐢𝐠𝐧𝐢𝐧𝐠 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 | 𝐄𝐂𝐒 ✕ 𝐈𝐀𝐒𝐋𝐂 | 𝐁𝐆𝐈𝐂𝐂 𝟐𝟎𝟐𝟔

During BGICC 2026, a significant milestone was achieved with the signing of a Memorandum of Understanding (MoU) between the Egyptian Cancer Society (ECS) and the International Association for the Study of Lung Cancer (IASLC).

This strategic partnership aims to advance lung cancer research, enhance education and training, and strengthen collaborative scientific efforts at both regional and global levels.

🤝 A shared commitment to excellence
🫁 Advancing lung cancer research and care
🌍 Global collaboration with local impact

Together, we turn collaboration into action—driving progress in lung cancer outcomes.
🎗️ A meaningful step forward, made possible at BGICC 2026.

𝐃𝐚𝐲 𝟐 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 | 𝐏𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐲 𝐂𝐨𝐮𝐫𝐬𝐞 – 𝟏𝟖𝐭𝐡 𝐁𝐆𝐈𝐂𝐂

A strong beginning to a journey of precision and insight.
From foundational concepts to advanced diagnostic perspectives, Day 2 delivered high-impact learning and meaningful scientific exchange.

🔬 Expert-led pathology insights
🧪 Practical discussions shaping diagnostic excellence
🌍 Global perspectives advancing cancer pathology
🤝 Knowledge shared, standards elevated

The science is evolving. The vision is clear.
🎗️ This is BGICC 2026.

𝟏𝟖𝐭𝐡 𝐁𝐆𝐈𝐂𝐂 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

A powerful start to a global mission.

Inspiring leaders, impactful conversations, and world-class scientific exchange set the tone from the very first day.

🌍 Global expertise on one stage
🧠 Forward-thinking discussions shaping cancer care
🤝 Collaboration that transcends borders

Momentum is building. Voices are united.
🎗️ This is BGICC 2026.

𝐂𝐨𝐥𝐩𝐨𝐬𝐜𝐨𝐩𝐲 𝐂𝐨𝐮𝐫𝐬𝐞 – 𝟏𝟖𝐭𝐡 𝐁𝐆𝐈𝐂𝐂

Focused training, expert guidance, and practical learning defined an impactful colposcopy course aimed at strengthening early detection and prevention strategies in gynecologic oncology.
Day 1 emphasized precision, accuracy, and clinical confidence in cervical cancer screening and diagnosis.

🔍 Hands-on colposcopic techniques
🧬 Early detection & precancerous lesion assessment
📊 Case-based learning for real-life practice
🤝 Expert mentorship enhancing diagnostic skills

Detect early. Act precisely. Protect lives.
🎗️ This is BGICC 2026.

𝐃𝐚𝐲 𝟏 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 | 𝐍𝐮𝐫𝐬𝐢𝐧𝐠 𝐂𝐨𝐮𝐫𝐬𝐞 – 𝟏𝟖𝐭𝐡 𝐁𝐆𝐈𝐂𝐂

Compassion, clinical expertise, and patient advocacy took center stage in an inspiring nursing course focused on excellence in oncology care.
Day 1 highlighted the essential role of oncology nurses in delivering safe, holistic, and patient-centered treatment.

💉 Evidence-based oncology nursing practices
🎗️ Symptom management and supportive care
🧠 Enhancing patient safety and quality of life
🤝 Team-based care across oncology disciplines

Caring with knowledge. Supporting with strength.
🎗️ This is BGICC 2026.